Biomarkers in the Brain Oxygen Optimization in Severe Traumatic Brain Injury Trial

Description

BioBOOST is a multicenter, observational study of the effect of derangements in brain physiologic parameters on brain injury biomarker levels in patients with severe traumatic brain injury.

Conditions

TBI (Traumatic Brain Injury)

Talk to us

Study Overview

On this page

Study Details

Study overview

BioBOOST is a multicenter, observational study of the effect of derangements in brain physiologic parameters on brain injury biomarker levels in patients with severe traumatic brain injury.

Biomarkers in the Brain Oxygen Optimization in Severe Traumatic Brain Injury Trial (BioBOOST)

Biomarkers in the Brain Oxygen Optimization in Severe Traumatic Brain Injury Trial

Condition
TBI (Traumatic Brain Injury)
Intervention / Treatment

-

Contacts and Locations

Ann Arbor

University of Michigan, Ann Arbor, Michigan, United States, 48109

Philadelphia

Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States, 19104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Enrolled in BOOST-3 (this is an ancillary study to the BOOST-3 trial)
  • * BOOST-3 participant is enrolled at a BioBOOST site
  • * Able to maintain initial blood sample within 24 hours of injury
  • * Provide proxy informed consent
  • * Profoundly anemic (subjects who are profoundly anemic require blood transfusion)
  • * Age less than 18 years

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Pennsylvania,

Study Record Dates

2027-12-31